← All trials
NCT03521141
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 18, 2018
- Primary completion
- Mar 1, 2019
- Completion date
- Aug 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 68
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Vanderbilt UniversityLead sponsor
- Meharry Medical CollegeCollaborator
- Meharry Medical CollegeOverall official - principal investigator
- Vanderbilt UniversityOverall official - principal investigator
- Vanderbilt UniversityOverall official - principal investigator
- Vanderbilt UniversityReponsible party - principal investigator
- Tennessee State UniversityCollaborator
- Tennessee State UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.